logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

LIANLIAN (02598) spent 4.97 million Hong Kong dollars on April 13 to repurchase 800,000 shares.

date
19:36 13/04/2026
avatar
GMT Eight
The online platform, Lianlian Numbers (02598), announced on April 13, 2026, that it will spend 4.97 million Hong Kong dollars to repurchase 800,000 shares.
LIANLIAN (02598) announced on April 13, 2026 that it will spend HK$4.97 million to repurchase 800,000 shares.
Related Articles
HK Stock
CSSC Offshore & Marine Engineering (00317) announced a 95.16% to 133.11% year-on-year increase in its expected first-quarter net profit attributable to shareholders to approximately RMB 360 million to RMB 430 million.
HK Stock
CHINA CHENGTONG (00217) subsidiary enters into a sale-leaseback agreement with Huadian Datong New Energy.
Fosun Pharma Industrial Pte.Ltd. increases its stake in SISRAM MED (01696) by approximately 335 million shares at a price of HK$3.34 per share.
CSSC Offshore & Marine Engineering (00317) announced a 95.16% to 133.11% year-on-year increase in its expected first-quarter net profit attributable to shareholders to approximately RMB 360 million to RMB 430 million.
HK Stock
CHINA CHENGTONG (00217) subsidiary enters into a sale-leaseback agreement with Huadian Datong New Energy.
HK Stock
Fosun Pharma Industrial Pte.Ltd. increases its stake in SISRAM MED (01696) by approximately 335 million shares at a price of HK$3.34 per share.
RECOMMEND
Deloitte China Reports Three Mega Hong Kong IPOs Among Global Top Five In Q1
Deloitte China Reports Three Mega Hong Kong IPOs Among Global Top Five In Q1
icon
09/04/2026
Token Wave Reshapes China’s Internet Landscape
Token Wave Reshapes China’s Internet Landscape
icon
09/04/2026
State‑Owned Six Banks Saw Consumer Loan Balances Rise Over RMB 55 Billion Last Year, Five Banks Grew Above 16% — Will The Surge Continue In 2026?
State‑Owned Six Banks Saw Consumer Loan Balances Rise Over RMB 55 Billion Last Year, Five Banks Grew Above 16% — Will The Surge Continue In 2026?
icon
09/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.